Skip to content Skip to left sidebar Skip to footer

Author: Aimee Lin

COVID-19 Vaccine Provider Bimonthly Forum

COVID-19 Vaccine Provider Bimonthly Forum

Please join our COVID-19 Vaccine Provider Bimonthly Forum tomorrow at 5PM!

The COVID-19 Vaccine Provider Bimonthly Forum will cover topics including EUA updates, storage and handling, provider questions, and any other important information regarding COVID-19 Vaccines.

The forum will be held every other Thursday at 5PM from 11/4/2021 until 12/23/2021.

COVID-19 Vaccine Provider Bimonthly Forum

Webinar Link: https://global.gotomeeting.com/join/314867021

You can also dial in using your phone.
United States: +1 (786) 535-3211

Access Code: 314-867-021

Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 314 867 021
Or dial directly: 314867021@67.217.95.2 or 67.217.95.2##314867021

New to GoToMeeting?
Get the app now and be ready when your first meeting starts: https://global.gotomeeting.com/install/828347453

Thank you for keeping Philadelphia safe and healthy. Please email covidproviders@phila.gov if you have any questions.

Thanksgiving Holiday Vaccine Ordering Changes

Thanksgiving Holiday Vaccine Ordering Changes

Please make note of the following changes in COVID-19 vaccine shipping around the end of November:

  • No vaccine orders will be delivered during November 24th-28th.
  • Orders must be placed next week on Monday, November 15th, and the following week, on Monday, November 22nd by 5PM in order to be processed due to holiday ordering cadence.
  • Vaccine delivery will resume on Monday, November 29.
  • Please plan to order order early to ensure vaccine will arrive on time prior to the holiday week.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.

Pfizer 5-11 Vials and Expiration Dates: Label Information

Pfizer 5-11 Vials and Expiration Dates: Label Information

Please refer to the bullets below for expiration dates and label information regarding the Pediatric Pfizer COVID-19 Vaccine for children ages 5-11. Pfizer COVID-19 Vaccine: 5 through 11 years formulation (orange cap) 
  • Formulation does NOT have expiration printed on vial
  • Instead, each vial has the lot number and date of manufacture printed on the label
  • Date on the label is NOT the expiration date

Expiration Date:

Pfizer DOES NOT have a tool to find expiration dates. The QR code on the label is a link to the EUA factsheetThe Pfizer pediatric formula has a 6-month expiration if held frozen at ultra-low temperature (ULT).
  • Manufacturing date + 6 months = expiration date.
    • eg. Vials dated 8/2021 expire the last day of 01/2022.
  • The expiration date will be indicated in PhilaVax when you accept your shipment.

Storage and Handling:

Follow EUA recommendations for storage of the Pfizer 5 through 11 years formulation:
  • Do NOT store in a standard freezer.
  • Store in ultra-low temperature freezer below -60°C (-76°F) for up to 6 months
  • Store in refrigerator between 2°C and 8°C (36°F and 46°F) for up to 10 weeks
If not used within 10 weeks, the vaccine should be discarded. Use these Beyond Use Date (BUD) labels to date the Pfizer 5-11 in your refrigerator.
Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.

Co-Administer COVID-19 Vaccines!

Co-Administer COVID-19 Vaccines!

Dear COVID-19 Provider,

All COVID-19 vaccines may be co-administered with other routine vaccinations! Patients may receive any other vaccine at the same time as their COVID-19 vaccine.

The Philadelphia Department of Public Health (PDPH) encourages all providers to help keep their patients up to date on their routine vaccinations. PDPH asks providers to remember “CAT” when they see patients for their COVID-19 vaccine.

What Does CAT Stand For?

C: Check PhilaVax IIS to see what routine vaccinations your patient is missing.

A: Ask the patient if they’d like their flu shot or another routine vaccination today.

T: Talk to your patient about the importance of getting vaccinated – if they are here to get their COVID-19 vaccine, they should also protect themselves from other viruses!

Thank your for helping keep Philadelphia safe from COVID-19. If you have any questions please contact us at vaccines@phila.gov.

CDC Recommends Pediatric COVID-19 Vaccine for 5-11 Year Olds

CDC Recommends Pediatric COVID-19 Vaccine for 5-11 Year Olds

Today, the Centers for Disease Control (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation that children ages 5 to 11 years old be vaccinated against COVID-19 with the Pfizer-BioNTech pediatric vaccine. The Philadelphia Department of Public Health (PDPH) asks all providers to begin vaccinating patients in this group as soon as possible.

All sites must finish ordering pediatric vaccine by 5PM today to ensure delivery next week. All pediatric orders must be submitted with a temperature log and closed reconciliation. If you are having trouble ordering, please email vaccines@phila.gov.

Ordering Information

To order doses for your 5-11-year-old patients:

  • Complete our interest survey
  • Complete a reconciliation
  • Submit your temperature data
  • Submit an order for the 5-11 patient doses in PhilaVax. Presentation is entered as “Pfizer COVID19 MRNA 5-11 years of age 10mcg/0.2ml”
  • Order minimum of 300 doses and must be in mutiples of 300 (ie. 300, 600, etc)

All steps must be completed by Wednesday November 3rd at 5pm.

Please note: Approved sites will be able to order Pfizer’s 5-11 Pediatric COVID-19 Vaccine each week. Sites will not need to order overstock.

Have Questions?

Have questions about Pfizer’s new formula? Need assistance with the reconciliation process or completing the survey? You can contact us at CovidProviders@phila.gov!
Thank for you helping keep Philadelphia safe and healthy! Together we can stop COVID-19!

COVID-19 Vaccine Provider Bimonthly Forum

COVID-19 Vaccine Provider Bimonthly Forum

The COVID-19 Vaccine Provider Bimonthly Forum will cover topics including EUA updates, storage and handling, provider questions, and any other important information regarding COVID-19 Vaccines.

The forum will be held every other Thursday at 5PM from 11/4/2021 until 12/23/2021.

COVID-19 Vaccine Provider Bimonthly Forum

Webinar Link: https://global.gotomeeting.com/join/314867021

You can also dial in using your phone.
United States: +1 (786) 535-3211

Access Code: 314-867-021

Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 314 867 021
Or dial directly: 314867021@67.217.95.2 or 67.217.95.2##314867021

New to GoToMeeting?
Get the app now and be ready when your first meeting starts: https://global.gotomeeting.com/install/828347453

Thank you for keeping Philadelphia safe and healthy. Please email covidproviders@phila.gov if you have any questions.

Moderna COVID-19 Vaccine Booster Dose Guidance

Moderna COVID-19 Vaccine Booster Dose Guidance

Dear COVID-19 Vaccine Providers,

On October 20, 2021, a Moderna COVID-19 Vaccine booster dose was authorized for specific populations listed below. The volume of a Moderna booster dose is .25mL.

Click here to read the full Moderna Booster Guidance Fact Sheet!

Booster Vaccination: One 0.25 mL dose

  • A booster dose may be administered intramuscularly at least 6 months after completing a primary series with the Moderna COVID-19 Vaccine to individuals:
    • 65 years of age and older
    • 18 through 64 years of age at high risk of severe COVID-19
    • 18 through 64 years of age with frequent institutional or occupational exposure to COVID-19

A single booster dose of the Moderna COVID-19 Vaccine (0.25 mL) may be administered as a heterologous (mix and match) booster dose following completion of primary vaccination with another authorized COVID-19 vaccine. The eligible population(s) and dosing interval for the mix and match booster dose are the same as those authorized for a booster dose of the vaccine used for primary vaccination.

Use of Multidose Vials of Moderna COVID-19 Vaccine

  • The Moderna COVID-19 Vaccine is supplied in two multiple-dose vial presentations:
    • A multiple-dose vial containing 5.5 mL
    • A multiple-dose vial containing 7.5 mL
  • Primary series doses of 0.5 mL and booster doses of 0.25 mL may be extracted from either vial presentation, preferentially using low dead-volume syringes and/or needles.
  • When extracting only primary series doses, depending on the syringes and needles used, a maximum of 11 doses (range: 10-11 doses) may be extracted from the vial containing 5.5 mL or a maximum of 15 doses (range: 13-15 doses) may be extracted from the vial containing 7.5 mL.
  • When extracting only booster doses or a combination of primary series and booster doses, the maximum number of doses that may be extracted from either vial presentation should not exceed 20 doses.
  • Do not puncture the vial stopper more than 20 times.
  • If the amount of vaccine remaining in the vial cannot provide a full dose of 0.5 mL or 0.25 mL, discard the vial and contents. Do not pool excess vaccine from multiple vials.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.

Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhalls

Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhalls

The Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhall will provide an overview of how to prepare and order pediatric COVID-19 Vaccine for the upcoming authorization of Pfizer for 5-11 year olds.

The training will occur multiple times a week:

  • 10/27/2021 Wednesday at 12PM and 5PM
  • 10/28/2021 Thursday at 12PM and 5PM
  • 10/29/2021 Friday at 12PM 
  • 11/02/2021 Tuesday at 12PM and 5PM
  • 11/04/2021 Thursday at 12PM and 5PM
  • 11/09/2021 Tuesday at 12PM and 5PM
  • 11/10/2021 Wednesday at 12PM 
  • 11/16/2021 Tuesday at 5PM 
  • 11/17/2021 Wednesday at 12PM 
  • 11/18/2021 Thursday at 5PM 

Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhall 

Please join my meeting from your computer, tablet or smartphone.

Webinar Link: https://global.gotomeeting.com/join/532390413

You can also dial in using your phone.
United States: +1 (408) 650-3123

Access Code: 532-390-413

Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 532 390 413
Or dial directly: 532390413@67.217.95.2 or 67.217.95.2##532390413

New to GoToMeeting?
Get the app now and be ready when your first meeting starts: https://global.gotomeeting.com/install/828347453

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email dphproviderhelp@phila.gov.

VFAAR Flu Vaccine Available for All Adults for the 2021-2022 Season

VFAAR Flu Vaccine Available for All Adults for the 2021-2022 Season

On October 15th, the Centers for Disease Control and Prevention (CDC) issued a special allowance for Vaccines for Adults at Risk (VFAAR) flu administration for the 2021-2022 season. VFAAR flu vaccine can now be administered to all adults regardless of insurance status during the 2021-2022 flu season.

Contrary to our default policy of allowing only the truly uninsured to receive VFAAR flu doses, this year, the CDC is making an exception to the screening requirement for flu only.

Why is VFAAR flu vaccine available to everyone?

The intent of removing the eligibility requirements for these federally funded doses is to ensure that everyone has access to flu vaccine. However, as providers, we ask you to follow the ordering algorithm below to ensure that throughout the flu season, you continue to have doses on hand for all your patients – especially the uninsured:

  • Use your existing privately purchased vaccine to vaccinate insured individuals.
  • Order a supply of VFAAR vaccines to vaccinate uninsured patients.
  • Do not miss opportunities. Vaccinate your patients with the most appropriate supply you have in stock.

Which supply of vaccine should I use?

  • Continue to vaccinate uninsured adults with flu from your VFAAR vaccine supply. As reminder, you cannot withhold a dose of VFAAR flu vaccine because a patient is unable to pay the administration fee.
  • Continue to vaccinate insured adults with flu from your privately purchased flu supply. However, if private doses are not available (because you’re waiting for your shipment or your supply is depleted), do not miss an opportunity; remember everyone is eligible to receive a dose from the VFAAR supply. And the VFAAR vaccines you use on private patients do not have to be replaced.
  • Do not charge anyone’s insurance for the cost of the VFAAR flu doses. This is considered fraud and could affect your ability to receive VFAAR doses going forward. You can charge patients’ insurance an administration fee for doses of VFAAR flu that are administered to insured patients.
  • Use the flowchart below to assist you with identifying the correct supply:

Order Today!

Remember to order VFAAR flu vaccine as needed throughout the 2021-2022 flu season. If you have any questions about your VFAAR supply contact Jillian Brown at jillian.brown@phila.gov for assistance.

Visit our Flu Page on our website for more information on what vaccines are available and to gain access to flu resources and free print materials.

Thank for your helping to keep Philadelphia safe from the flu!

Updated COVID-19 Vaccine Booster Shot Guidance

Updated COVID-19 Vaccine Booster Shot Guidance

Dear COVID-19 Providers,The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have found that a booster dose of Pfizer, Moderna, or Janssen (Johnson & Johnson) are safe and effective at decreasing the risk of severe disease and infection in specific populations.

Please refer to the bullets below for specific guidance from the CDC and FDA about booster doses.

Guidance for populations who received Pfizer or Moderna as their primary vaccine series against COVID-19:

  • People 50+ years and older at high risk of severe disease are advised to receive the Pfizer-BioNTech or Moderna booster shot at least 6 months after completing their primary series (i.e., first 2 doses of Pfizer or Moderna).
  • Populations at high risk of infection based on occupation are also eligible to receive the Pfizer or Moderna booster shot at least 6 months after completing the primary series.
  • The Pfizer and Janssen boosters are identical to the doses provided in the initial series, while the Moderna booster dose is half the original dose, 50µg in 0.25mL.

Guidance for populations who received a single dose Janssen primary series:

  • People 18 years and older who received a single dose Janssen primary series should receive a single Janssen COVID-19 booster dose at least 2 months after completing their primary series.

Heterologous (“Mix and Match”) Booster Dose:

  • A single booster dose of any of the FDA approved or authorized COVID-19 vaccines may be administered as a heterologous booster dose following completion of primary vaccination with a different FDA approved or authorized COVID-19 vaccine. Individual benefit-risk assessment may inform which booster product to administer.
  • The dosing interval of a mix and match booster dose should be the same as authorized for the primary vaccination series for eligible persons (i.e., a mix and match booster dose should be administered at least 6 months following a primary series of Pfizer or Moderna and at least 2 months following a primary single-dose Janssen vaccine).
  • Mix and match dosing is acceptable for booster doses only. It should not be considered for primary vaccine series or 3rd doses for moderately to severely immunocompromised persons.

Co-administration of Booster Doses with other Vaccines:

  • COVID-19 vaccine booster doses (Pfizer, Moderna, or Janssen) may be given with other vaccines, without regard to timing, including co-administration of a COVID-19 vaccine and other vaccines on the same day.
  • If multiple vaccines are administered at a single visit, administer each injection in a different injection site.
  • The booster dose is not authorized for anyone under the age of 18, regardless of medical condition or occupation.

Resources:

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.